Mikoto Pharma Private Limited - Company Profile

It is a business services private limited company based in East Delhi, Delhi, India, established in 2024.
2024 East Delhi, Delhi, India Active
Last Updated:
Access Report
About Mikoto Pharma Private Limited

Mikoto Pharma Private Limited, a active private limited company, was established on 31 January 2024 in East Delhi, Delhi, India. it holds CIN: U46497DL2024PTC425997. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Abhishek Kumar (Director), Rahul Yadav (Director), Anshu Nanda (Director). Past directors included Rahul Yadav, Arpit Yadav. It is based at X/819 First Floor, Chand Mohalla,, Raghubar Pura, Gandhi Nagar, Near Mandir And Radhe Shyam Chakki, East Delhi, Delhi, 110031.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U46497DL2024PTC425997

  • Registration Number

    425997

  • Incorporation Date

    31 January 2024

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 2 Year, 5 Months
Company report

Mikoto Pharma Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Mikoto Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Mikoto Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Abhishek Kumar Director 14 Nov 2025 Current
Rahul Yadav Director 31 Jan 2024 Current
Anshu Nanda Director 31 Jan 2024 Current
Rajiv Yadav Director 14 Nov 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 15 Nov 2025 Past
Pramod Abcsdd Director 15 Nov 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Mikoto Pharma.

Enhance accessibility to Mikoto Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Mikoto Pharma revenue growth over time
Mikoto Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Mikoto Pharma?

Unlock access to Mikoto Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Mikoto Pharma?

Unlock and access historical data on people associated with Mikoto Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mikoto Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mikoto Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Mikoto Pharma
Recent Activity within the Organization
  • Director Appointment

    The activity Abhishek Kumar was appointed as a Director was appointed as a Director on 14 Nov 2025 & has been associated with this company since 7 months 19 days . was completed.

  • Director Appointment

    Progress on Rajiv Yadav was appointed as a Director was appointed as a Director on 14 Nov 2025 & has been associated with this company since 7 months 19 days . was documented.

  • Director Appointment

    Progress on Rahul Yadav was appointed as a Director was appointed as a Director on 31 Jan 2024 & has been associated with this company since 2 years 5 months . was documented.

  • Director Appointment

    Anshu Nanda was appointed as a Director was appointed as a Director on 31 Jan 2024 & has been associated with this company since 2 years 5 months . was recorded as a recent event.

  • Company Incorporation

    The activity Mikoto Pharma Private Limited was registered on 31 Jan 2024 with Roc Delhi & aged 2 years 5 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Mikoto Pharma Private Limited?

The CIN of Mikoto Pharma Private Limited is U46497DL2024PTC425997.

Where is Mikoto Pharma Private Limited headquartered?

Mikoto Pharma Private Limited is headquartered at X/819 First Floor, Chand Mohalla,, Raghubar Pura, Gandhi Nagar, Near Mandir And Radhe Shyam Chakki, East Delhi, Delhi, 110031.

When was Mikoto Pharma Private Limited incorporated?

Mikoto Pharma Private Limited was incorporated on 31 January 2024.

Who are the current directors of Mikoto Pharma Private Limited?

The current directors of Mikoto Pharma Private Limited are

Is Mikoto Pharma Private Limited a listed company?

Mikoto Pharma Private Limited is unlisted.

What is the capital structure of Mikoto Pharma Private Limited?

The authorized capital of Mikoto Pharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available